| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023301467 |
| P356 | DOI | 10.1038/SJ.BMT.1703661 |
| P698 | PubMed publication ID | 12209354 |
| P5875 | ResearchGate publication ID | 11180298 |
| P2093 | author name string | Y Tanaka | |
| H Hirai | |||
| K Mitani | |||
| S Mori | |||
| Y Arai | |||
| S Chiba | |||
| Y Kanda | |||
| Y Nannya | |||
| T Hamaki | |||
| M Kami | |||
| S Miyakoshi | |||
| E Kusumi | |||
| Japan Hematology and Oncology Clinical Study Group (J-HOCS) | |||
| Y Mutou | |||
| P2860 | cites work | Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase | Q28291219 |
| Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation | Q33968089 | ||
| Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. | Q33974273 | ||
| Factors influencing detection of quantitative cytomegalovirus antigenemia | Q37073815 | ||
| Detection of human cytomegalovirus DNA by real-time quantitative PCR. | Q39459320 | ||
| Quantification of human cytomegalovirus DNA by real-time PCR. | Q39463508 | ||
| Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan | Q43583148 | ||
| Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients | Q43660968 | ||
| Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group | Q44393577 | ||
| Cytomegalovirus DNA in the sera of patients with cytomegalovirus pneumonia | Q44894727 | ||
| Transplantation and the Second Law of Thermodynamics. | Q52059831 | ||
| Quantitative analysis of cytomegalovirus load using a real-time PCR assay. | Q64953713 | ||
| Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation | Q72015324 | ||
| Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant | Q72940232 | ||
| Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial | Q72940234 | ||
| Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients | Q73335173 | ||
| Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation | Q74122342 | ||
| Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines | Q77292067 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| cytomegaloviral disease | Q2076966 | ||
| P304 | page(s) | 315-319 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation | |
| P478 | volume | 30 |
| Q43228476 | A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT. |
| Q24293059 | Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication |
| Q42182292 | Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation |
| Q36086432 | Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication. |
| Q33815957 | Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers |
| Q37284695 | Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients |
| Q37310186 | Construction and Evaluation of Cytomegalovirus DNA Quantification System with Real-Time Detection Polymerase Chain Reaction |
| Q40232738 | Cytomegalovirus Kinetics Following Primary Infection in Healthy Women |
| Q26771385 | Cytomegalovirus infection in the bone marrow transplant patient |
| Q35110913 | Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients |
| Q40343812 | Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients |
| Q42236773 | Dried urine spots for detection and quantification of cytomegalovirus in newborns |
| Q101166479 | Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data |
| Q34989242 | Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides |
| Q36172394 | Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene. |
| Q37544751 | In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action. |
| Q37512197 | Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections |
| Q35746009 | Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation |
| Q91911829 | Insuffisance Respiratoire Aiguë chez le patient immunodéprimé : Quelle approche diagnostique ? |
| Q60031666 | Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees |
| Q36933563 | Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. |
| Q35922545 | Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients |
| Q43883386 | Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation |
| Q42616123 | Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors |
| Q33785773 | Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. |
| Q44712377 | Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease |
| Q41830479 | Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety. |
| Q37026623 | Wnt modulating agents inhibit human cytomegalovirus replication |
Search more.